Vesalio Reports Positive Results in Early NeVa™ Human Thrombectomy Procedures and Recently Published Pre-Clinical Data
Nashville, TN, March 22, 2018 –(PR.com)– Vesalio announces it has completed European enrollment of the first twenty-five human cases in a post-market registry of the proprietary NeVa™ neurothrombectomy platform...
Read More